Belo Horizonte, Brazil

Paulo Sérgio Lacerda Beirão

This inventor holds 1 USPTO granted patent. Top assignee: Universidade Federal De Minas Gerais. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paulo Sérgio Lacerda Beirão. Retrieved from https://idiyas.com/inventor/paulo-sérgio-lacerda-beirão

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paulo Sérgio Lacerda Beirão: Innovator in Pharmaceutical Peptides

Introduction

Paulo Sérgio Lacerda Beirão is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of synthetic peptides. His work focuses on innovative solutions for medical conditions, showcasing his expertise and dedication to advancing healthcare.

Latest Patents

One of Beirão's key inventions is the synthetic PnTx(19) peptide, which consists of 19 amino acids derived from the native toxin PnTx2-6 of the Phoneutria nigriventer spider. This invention is particularly relevant for its application in treating erectile dysfunction and enhancing erectile function. The patent highlights the potential of this synthetic peptide in pharmaceutical compositions, marking a significant advancement in therapeutic options.

Career Highlights

Beirão is affiliated with the Universidade Federal de Minas Gerais, where he contributes to research and innovation in the field of pharmaceuticals. His academic background and research endeavors have positioned him as a leading figure in peptide synthesis and its applications in medicine.

Collaborations

Throughout his career, Beirão has collaborated with esteemed colleagues, including Carolina Nunes Da Silva and Flávia De Marco Almeida. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their respective fields.

Conclusion

Paulo Sérgio Lacerda Beirão's contributions to the development of synthetic peptides represent a significant advancement in pharmaceutical science. His innovative work continues to pave the way for new treatments and improved healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…